SCHEMBL28290434

SCHEMBL28290434

CC(C)(C)C(=O)ON1CCN(Cc2cncs2)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRPK1 Q96SB4 4/20 0.39
OPRD1 P41143 1/20 0.37
KCNH2 Q12809 1/20 0.37
ARG1 P05089 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.34
HSD17B10 Q99714 1/20 0.34
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
JAK2 O60674 1/20 0.33
JAK1 P23458 1/20 0.33
TYK2 P29597 1/20 0.33
JAK3 P52333 1/20 0.33
KDM1A O60341 1/20 0.33
PARP15 Q460N3 1/20 0.33
PARP10 Q53GL7 1/20 0.33
PRKCQ Q04759 1/20 0.33
PRKCD Q05655 1/20 0.33
GRM5 P41594 1/20 0.32
LTA4H P09960 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2733534 0.80 GPR119 (0.46) SRPK1SMN1; SMN2HSD17B10
SCHEMBL28289204 0.77 KDM4E (0.34) PRKCQPRKCD
SCHEMBL27890354 0.75 RAB9A (0.37) ARG1SMN1; SMN2NPC1RAB9APARP15
SCHEMBL27844699 0.75 KDM4E (0.51) SMN1; SMN2
SCHEMBL28289064 0.74 MGLL (0.40) SRPK1PRKCQPRKCD
SCHEMBL28872036 0.74 TSHR (0.51) SMN1; SMN2
SCHEMBL28289061 0.74 OPRD1 (0.40) SRPK1OPRD1KCNH2
SCHEMBL209854 0.74 ARG1 (0.42) SRPK1OPRD1KCNH2ARG1SMN1; SMN2
SCHEMBL27844847 0.73 CHRNB2 (0.54) TDP1
SCHEMBL28305078 0.73 SCN9A (0.38) SRPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109563092-A It can be used as the 2- phenylimidazole of the active inhibitor of mammal tyrosine kinase ROR1 simultaneously [4,5-B] pyridine -7- amine derivative 坎塞拉有限公司 2019-04-02 CN disclosed